Dr. Robin Shattock

Biography

Professor Robin Shattock is the Head of the Mucosal Infection Immunity Department of Medicine at Imperial College London. His research focuses on understanding the mechanisms of mucosal infection development and developing novel preventative strategies suitable for resource-limited settings. He has been instrumental in establishing international collaborations aimed at the preclinical identification and development of HIV microbicide and vaccine candidates prior to formal clinical efficacy trials. Professor Shattock manages a diverse portfolio of research supported by a team of 26 staff members, which includes researchers, PhD students, and clinical trial and project managers. He has published over 160 peer-reviewed articles in his area and has secured funding from major organizations including the European Commission, Bill & Melinda Gates Foundation, Wellcome Trust, MRC, and NIH. His group is responsible for the DNAVAC project, which applies state-of-the-art DNA vaccination and immune monitoring technologies to understand vaccine-induced antibody responses at the single-cell molecular level. He also leads several collaborative projects and consortia aimed at developing cutting-edge immunization technologies and improving vaccine safety. His research significantly contributes to the efforts to combat HIV and enhance vaccine development.

Research Interests

Experience